Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?

Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis? Clin Exp Rheumatol. 2015 Sep-Oct; 33(5 Suppl 93):S82-93.

View in: PubMed

subject areas

Arthritis, Psoriatic
Arthritis, Rheumatoid
Clinical Trials as Topic
Data Interpretation, Statistical
Endpoint Determination
Evidence-Based Medicine
Humans
Immunosuppressive Agents
Methotrexate
Remission Induction
Research Design
Time Factors
Treatment Outcome

authors with profiles

Theodore Pincus